FDA Announces Continuation of Voluntary Quality Management Maturity Prototype Assessment Protocol Evaluation Program
April 23, 2025
April 23, 2025
WASHINGTON, April 23 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration (FDA) announced the continuation of the voluntary Quality Management Maturity (QMM) Prototype Assessment Protocol Evaluation Program for the second year.
The program, which is managed by the Center for Drug Evaluation and Research (CDER), aims to enhance the quality management practices within drug manufacturing establishments. These practices are designed to prioritize pat . . .
The program, which is managed by the Center for Drug Evaluation and Research (CDER), aims to enhance the quality management practices within drug manufacturing establishments. These practices are designed to prioritize pat . . .